December 7, 2011 | 9:45-10:45 a.m. PT
Once dubbed the “plague” of patent claims by the Federal Circuit, the defense of inequitable conduct was often pled and caused practitioners to submit reams of prior art to the PTO. After the Federal Circuit’s decision in Therasense, the inequitable conduct defense has become much more difficult to prove. In this session, leading practitioners examine the practical effect of Therasense and what the future of inequitable conduct will be now that Rule 56 has been discarded, the “sliding scale” is gone, and the bar has been raised for both prongs of the test for inequitable conduct:
Sponsored by:
American Conference Institute 2nd Annual Forum on Paragraph IV Disputes
Register Online at http://www.americanconference.com/paragraphivsnf